|
Research
Studies
Urology
Selenium
and Vitamin E Cancer Prevention Trial (SELECT)
The
purpose of this study is to evaluate whether selenium, vitamin
E or the combination of selenium and vitamin E can prevent
or reduce the occurrence of prostate cancer... Read
more
A
Pilot Study of the Supplementation of Genistein Concentrated
Polysaccharide, GCPTM, in Men with Prostate Cancer
before Radical Retropubic Prostatectomy
The
effects of this nutritional supplement on the biology (e.g.,
cell death, angiogenesis) of prostate cancer will be evaluated...
Read more
Gastroenterology
Colon
Polyp Prevention Study
The
goal of the current trial is to determine whether celecoxib,
a selective COX-2 inhibitor, can prevent the recurrence
of colorectal adenomas... Read more
Chemoprevention
Trial in Patients with Barrett’s-associated Dysplasia
Subjects
with Barrett’s esophagus who have either low or high grade
esophageal dysplasia will be eligible to be randomized to
take either celecoxib, a selective cyclooxygenase-2 (COX-2)
inhibitor, or placebo... Read more
Educating
Primary Care Physicians Regarding Colorectal Cancer Screening
The
underlying premise of this randomized trial, funded by the
American Cancer Society, is that the main barrier to the
receipt of appropriate screening is the primary care physician
who neglects to make an appropriate recommendation. As a
result, studies over the past decade focused on educating
community primary care physicians on the latest tools and
guidelines for cancer prevention and control using a method
called “academic detailing”... Read more
Lung
The
NY-ELCAP CT Screening study
The
New York Early Lung Cancer Action Program, known as NY-ELCAP,
is a study to determine if low-dose CT scanning is an effective
screening technique to detect lung cancer in its earliest
stages for people at high risk for the disease... Read
more
Breast
and Ovarian
Study
of Tamoxifen and Raloxifene (STAR)
Researchers
plan to study 22,000 postmenopausal women at increased risk
of breast cancer and will determine whether the osteoporosis
prevention drug raloxifene (Evista) is as effective in reducing
the chance of developing breast cancer as tamoxifen (Nolvadex)...
Read more
Dermatology
Skin
Study on the Cyclooxygenase-2 (COX-2) Inhibitor Celecoxib
in Skin Cancer
The
Department of Dermatology is embarking on a study to test
the hypothesis that the COX-2 inhibitor, celecoxib, administered
orally over a period of 24 months, will prevent the development
of basal cell carcinomas in patients with the nevoid basal
cell carcinoma syndrome... Read more
Tobacco
Cessation
Study
to Test Treatments Against Smoking Relapse
The
study will test whether people who have just quit smoking
with the help of Zyban, the nicotine patch, and counseling
can benefit from a four-month maintenance regime of medication
and supportive counseling... Read more
|
